CV outcomes better with SGLT2 inhibitor than DPP4 inhibitor in T2DM studyNovember 4, 2017DiabetesLipid Disorders
Better trials, more cooperation needed to improve continuous glucose monitoring devicesOctober 29, 2017Diabetes
FDA panel advises approval of semaglutide to lower HbA1c in patients with type 2 diabetesOctober 19, 2017Diabetes
Oral semaglutide achieves outcomes similar to those of subcutaneous semaglutideOctober 18, 2017Diabetes
